Complete response and immune-mediated adverse effects with checkpoint blockade: Treatment of mismatch repair-deficient colorectal neuroendocrine carcinoma

Julia Whitman; Adel Kardosh; Luis Diaz; Lawrence Fong; Thomas Hope; Courtney Onodera; Nancy Joseph; Dung Le; George Fisher; Emily Bergsland

doi:10.1200/PO.19.00098

Complete response and immune-mediated adverse effects with checkpoint blockade: Treatment of mismatch repair-deficient colorectal neuroendocrine carcinoma

Julia Whitman, Adel Kardosh, Luis Diaz, Lawrence Fong, Thomas Hope, Courtney Onodera, Nancy Joseph, Dung Le, George Fisher, Emily Bergsland

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	1-7
Number of pages	7
Journal	JCO Precision Oncology
Volume	3
DOIs	https://doi.org/10.1200/PO.19.00098
State	Published - 2019

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/PO.19.00098

Cite this

@article{dabe6e311807439f8aec057490e7e7c8,

title = "Complete response and immune-mediated adverse effects with checkpoint blockade: Treatment of mismatch repair-deficient colorectal neuroendocrine carcinoma",

author = "Julia Whitman and Adel Kardosh and Luis Diaz and Lawrence Fong and Thomas Hope and Courtney Onodera and Nancy Joseph and Dung Le and George Fisher and Emily Bergsland",

note = "Funding Information: Supported by the Stanford Cancer Institute and the University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, National Cancer Institute–designated comprehensive cancer centers; Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins; The Swim Across America Laboratory at Johns Hopkins; and Merck.",

year = "2019",

doi = "10.1200/PO.19.00098",

language = "English (US)",

volume = "3",

pages = "1--7",

journal = "JCO Precision Oncology",

issn = "2473-4284",

publisher = "American Society of Clinical Oncology",

}

TY - JOUR

T1 - Complete response and immune-mediated adverse effects with checkpoint blockade

T2 - Treatment of mismatch repair-deficient colorectal neuroendocrine carcinoma

AU - Whitman, Julia

AU - Kardosh, Adel

AU - Diaz, Luis

AU - Fong, Lawrence

AU - Hope, Thomas

AU - Onodera, Courtney

AU - Joseph, Nancy

AU - Le, Dung

AU - Fisher, George

AU - Bergsland, Emily

N1 - Funding Information: Supported by the Stanford Cancer Institute and the University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, National Cancer Institute–designated comprehensive cancer centers; Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins; The Swim Across America Laboratory at Johns Hopkins; and Merck.

PY - 2019

Y1 - 2019

UR - http://www.scopus.com/inward/record.url?scp=85086386417&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086386417&partnerID=8YFLogxK

U2 - 10.1200/PO.19.00098

DO - 10.1200/PO.19.00098

M3 - Article

AN - SCOPUS:85086386417

SN - 2473-4284

VL - 3

SP - 1

EP - 7

JO - JCO Precision Oncology

JF - JCO Precision Oncology

ER -

Complete response and immune-mediated adverse effects with checkpoint blockade: Treatment of mismatch repair-deficient colorectal neuroendocrine carcinoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this